Почетна › Езофагеален аденокарцином › Њујорк › New York City
Клинички испитувања за Езофагеален аденокарцином во New York City, NY
18 студии за Езофагеален аденокарцином бараат учесници на локации во и околу New York City (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Се регрутираФаза 2/3
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Се регрутираФаза 3
- Manhattan Eye Ear and Throat Hospital, New York
- NYP/Weill Cornell Medical Center, New York
- Lenox Hill Hospital, New York
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
Се регрутираФаза 2/3
- Memorial Sloan Kettering Cancer Center, New York
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Се регрутираФаза 1/2
- Memorial Sloan-Kettering Cancer Center, New York
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
Се регрутираФаза 2/3
- Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
- Rockefeller Outpatient Pavilion (53rd Street), New York
- Memorial Sloan Kettering Cancer Center - Main Campus, New York
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Се регрутираФаза 1
- Columbia University Irving Medical Center, New York
Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinomas
Се регрутираФаза 2
- Weill Cornell Medicine - New York Presbyterian Hospital, New York
A Study of 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma
Се регрутираФаза 1/2
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
Се регрутира
- Columbia Universtiy, New York
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Се регрутираФаза 3
- Research Site, New York
- Research Site, New York
- Research Site, New York
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Се регрутираФаза 1/2
- NYU Langone Health, New York
- Icahn School of Medicine At Mount Sinai Prime, New York
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Се регрутираФаза 1
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
- Icahn School of Medicine at Mount Sinai, New York
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Се регрутираФаза 1
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New York
- Columbia University Irving Medical Center, New York
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
Се регрутира
- Weill Cornell Medicine, New York
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Се регрутираФаза 1
- Research Site, New York
Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma
Се регрутираФаза 2
- Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
Се регрутираФаза 1
- NYU Langone, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer
Се регрутираФаза 1
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Испитувања за Езофагеален аденокарцином во други градови
- Boston, MA13 студии
- Houston, TX12 студии
- Nashville, TN11 студии
- Arlington, VA11 студии
- Durham, NC10 студии
- Rochester, MN9 студии
- Baldwin Park, CA9 студии
- St. Louis, MO9 студии
- Jacksonville, FL9 студии
- Queens, NY9 студии
- Los Angeles, CA9 студии
- Philadelphia, PA8 студии
Други студии во New York City
- Рак на дојка136 студии
- Рак на бели дробови со не-мали клетки121 студија
- Рак (сите типови)109 студии
- Рак на простата103 студии
- Метастатски карцином93 студии
- Колоректален карцином78 студии
- Карцином на јајниците69 студии
- Рак на бели дробови60 студии
- Множен миелом60 студии
- Карцином на панкреасот60 студии
- Рак на ендометриумот52 студии
- Акутна миелоидна леукемија51 студија
Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.